Who makes Rectal Methadone administer during spinal surgery?

Rectal Methadone administer during spinal surgery is developed by Unity Health Toronto.

What development phase is Rectal Methadone administer during spinal surgery in?

Rectal Methadone administer during spinal surgery is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Rectal Methadone administer during spinal surgery

Unity Health Toronto · FDA-approved active Small molecule Quality 1/100

Rectal Methadone, administered during spinal surgery, is a marketed product by Unity Health Toronto with a key composition patent expiring in 2028. The drug's unique administration route during spinal surgery provides a distinct competitive advantage. The primary risk is the lack of robust trial results to support broader adoption and potential competition post-patent expiry.

At a glance

Generic name	Rectal Methadone administer during spinal surgery
Sponsor	Unity Health Toronto
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Perioperative Rectal Methadone in Spine Surgery (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Rectal Methadone administer during spinal surgery CI brief — competitive landscape report
Rectal Methadone administer during spinal surgery updates RSS · CI watch RSS
Unity Health Toronto portfolio CI